arrow
F

Francesca Maria Rossi

centro di riferimento oncologico di aviano (cro)
H指数:37
被引数:4,433

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Measurement of Immunoglobulin Intraclonal diversification refines the clinical impact of IGHV mutational status in chronic lymphocytic leukemia

免疫球蛋白同种型内多样化测量的结果细化了慢性淋巴细胞白血病中IGHV突变状态的临床影响。

Leukemia
IF13.4
2025-06-180
OAAI
The VLA-4 integrin is constitutively active in circulating chronic lymphocytic leukemia cells via BCR autonomous signaling: a novel anchor-independent mechanism exploiting soluble blood-borne ligands
LEUKEMIA
IF13.4
2024-08-141
OAAI
CD49d expression is included in a revised 4-factor model predicting outcome in patients with chronic lymphocytic leukemia treated with ibrutinib: A multicenter real-world experience
2024-07-151
OAAI
ERBB4-Mediated Signaling Is a Mediator of Resistance to PI3K and BTK Inhibitors in B-cell Lymphoid Neoplasms
2023-10-192
OA
ERBB4-mediated signaling is a mediator of resistance to BTK and PI3K inhibitors in B cell lymphoid neoplasms
2023-04-040
PRE
Clinical impact of TP53 disruption in chronic lymphocytic leukemia patients treated with ibrutinib: a campus CLL study
LEUKEMIA
IF13.4
2023-02-1813
OAAI
COVID-19 vaccination: Evaluation of humoral and cellular immunity after the booster dose in chronic lymphocytic leukemia patients
2023-01-091
OA
Resistance to PI3Kδ inhibitors in marginal zone lymphoma can be reverted by targeting the IL-6/PDGFRA axis
2022-04-289
OAAI
Elastin MIcrofibriL INterfacer1 (EMILIN-1) is an alternative prosurvival VLA-4 ligand in chronic lymphocytic leukemia
2021-11-225
PREAI
Impaired nodal shrinkage and apoptosis define the independent adverse outcome of NOTCH1 mutated patients under ibrutinib therapy in chronic lymphocytic leukemia
2020-07-3011
OAAI
Survival risk score for real-life relapsed/refractory chronic lymphocytic leukemia patients receiving ibrutinib. A campus CLL study
LEUKEMIA
IF13.4
2020-04-1421
PREAI
A laboratory-based scoring system predicts early treatment in Rai 0 chronic lymphocytic leukemia
2019-10-0317
OAAI
Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia

慢性淋巴细胞白血病BIRC3突变的生物学和临床意义

2019-08-0169
OAAI